Haleon PLC (HLN) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Total Revenue Chart for Haleon PLC

Haleon PLC (HLN) revenue for FY2025 was GBP 11.0B, a -1.8% change from FY2024. Haleon PLC's revenue grew from GBP 8.5B in 2019 to GBP 11.0B in 2025 (30.1% over 6 years). Earnings per share grew from GBP 0.12 in 2020 to GBP 0.11 in 2022 (-7.5%). Revenue compound annual growth rate: 5-year CAGR of 2.2%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (British Pounds)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
£32.13B
Implied Share Price
£3.65
Enterprise Value
£40.23B
Revenue (TTM)
£11.15B
EBITDA
£2.85B
Profit Margin
14.55%
Trailing P/E
20.29
Forward P/E
18.02
Price/Book (MRQ)
1.98
Price/Sales (TTM)
2.88
EV/EBITDA
14.21
EV/Revenue
3.58
Dividend Yield
1.96%
Book Value
£1.84
Free Cash Flow (FY2025)
£2.02B
Free Cash Flow Yield
6.27%

Snapshot as of 27th August 2026 — not point-in-time controlled, may lag the live market by a few days.